These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11285043)

  • 1. Hormone replacement therapy in healthy postmenopausal women: a randomized, placebo-controlled study of effects on coagulation and fibrinolytic factors.
    Gottsäter A; Rendell M; Hulthén UL; Berntorp E; Mattiasson I
    J Intern Med; 2001 Mar; 249(3):237-46. PubMed ID: 11285043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy in healthy postmenopausal women. Effects on intraplatelet cyclic guanosine monophosphate, plasma endothelin-1 and neopterin.
    Anwaar I; Rendell M; Gottsäter A; Lindgärde F; Hulthén UL; Mattiasson I
    J Intern Med; 2000 Apr; 247(4):463-70. PubMed ID: 10792560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in coagulation factors and fibrinolytic components of postmenopausal women receiving continuous hormone replacement therapy.
    Nozaki M; Ogata R; Koera K; Hashimoto K; Nakano H
    Climacteric; 1999 Jun; 2(2):124-30. PubMed ID: 11910665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 17 beta-oestradiol on variables of coagulation and fibrinolysis in postmenopausal women with type 2 diabetes mellitus.
    Brussaard HE; Leuven JA; Krans HM; Kluft C
    Vascul Pharmacol; 2002 Aug; 39(3):141-7. PubMed ID: 12616982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
    Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis.
    Teede HJ; McGrath BP; Smolich JJ; Malan E; Kotsopoulos D; Liang YL; Peverill RE
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1404-9. PubMed ID: 10807761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pulsed estrogen therapy on hemostatic markers in comparison with oral estrogen regimen in postmenopausal women.
    Basurto L; Saucedo R; Zárate A; Martínez C; Gaminio E; Reyes E; Hernandez M
    Gynecol Obstet Invest; 2006; 61(2):61-4. PubMed ID: 16192735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women.
    Salobir BG; Keber I; Vrabic L
    Fertil Steril; 2002 Dec; 78(6):1178-83. PubMed ID: 12477508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose oral combination of 17beta-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1.
    Borgfeldt C; Li C; Samsioe G
    Climacteric; 2004 Mar; 7(1):78-85. PubMed ID: 15259286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease.
    Lindoff C; Peterson F; Lecander I; Martinsson G; Astedt B
    Maturitas; 1996 May; 24(1-2):43-50. PubMed ID: 8794433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
    Walsh BW; Kuller LH; Wild RA; Paul S; Farmer M; Lawrence JB; Shah AS; Anderson PW
    JAMA; 1998 May; 279(18):1445-51. PubMed ID: 9600478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients.
    Park JS; Jung HH; Yang WS; Kim SB; Min WK; Chi HS
    Nephrol Dial Transplant; 2000 Nov; 15(11):1835-40. PubMed ID: 11071974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hormone replacement on hemostasis in spontaneous menopause.
    Demirol A; Baykal C; Kirazli S; Ayhan A
    Menopause; 2001; 8(2):135-40. PubMed ID: 11256874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight change and blood coagulability and fibrinolysis in healthy obese women.
    Rissanen P; Vahtera E; Krusius T; Uusitupa M; Rissanen A
    Int J Obes Relat Metab Disord; 2001 Feb; 25(2):212-8. PubMed ID: 11410822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature.
    Cosman F; Baz-Hecht M; Cushman M; Vardy MD; Cruz JD; Nieves JW; Zion M; Lindsay R
    Thromb Res; 2005; 116(1):1-13. PubMed ID: 15850603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regular Resistance Training Enhances Fibrinolytic Potential but Does Not Affect Coagulation.
    Nagelkirk PR; Soave K; Altherr C; Del Pozzi A
    Med Sci Sports Exerc; 2021 Nov; 53(11):2318-2323. PubMed ID: 34115732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature.
    Douketis JD; Gordon M; Johnston M; Julian JA; Adachi JR; Ginsberg JS
    Thromb Res; 2000 Jul; 99(1):25-34. PubMed ID: 11012376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.